4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Opioid-Related Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlezon, WA; Chartoff, E; Do Carmo, GP; Folk, JE; Negus, SS; Rice, KC | 1 |
Banks, ML; Folk, JE; Negus, SS; Rice, KC; Roma, PG | 1 |
2 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Opioid-Related Disorders
Article | Year |
---|---|
The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.
Topics: Animals; Behavior, Animal; Benzamides; Brain; Electric Stimulation; Opioid-Related Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Seizures; Self Stimulation | 2009 |
Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzamides; Cocaine; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Macaca mulatta; Male; Methadone; Opioid-Related Disorders; Pain; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, mu; Reinforcement, Psychology; Self Administration | 2011 |